| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5873258 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 5 Pages |
Abstract
Administration of intravenous tPA in dabigatran-treated patients is feasible. Although, the relationship between dabigatran concentrations and coagulation measures varies between laboratories, individual protocols, preferably based on TT, can be developed at acute stroke treatment centers.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Mahesh MBBS, MD, DM, Artur MD, PhD, FRCPC, Adam MD, Ashfaq MD, FRCPC, FAHA, Kenneth MD, PhD, FRCPC,